Thomas E. Ahlering
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Eflornithine in Treating Patients At High Risk of Developing Prostate Cancer (NCT00006101) | Thomas E. Ahlering | 1998-10-01 |
Track Thomas E. Ahlering automatically
Every clearance here is in the API, with alerts when new ones post.